Published in J Allergy Clin Immunol on September 01, 2005
Adiposity and Airway Inflammation in HIV-Associated Airway Disease (SHOP) | NCT02975258
Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma. Eur Respir J (2007) 2.16
The tumor necrosis factor family member LIGHT is a target for asthmatic airway remodeling. Nat Med (2011) 2.12
Bronchial smooth muscle remodeling involves calcium-dependent enhanced mitochondrial biogenesis in asthma. J Exp Med (2007) 1.91
Airway hyperresponsiveness is dissociated from airway wall structural remodeling. J Allergy Clin Immunol (2008) 1.76
Immunologic and inflammatory mechanisms that drive asthma progression to remodeling. J Allergy Clin Immunol (2008) 1.71
NET balancing: a problem in inflammatory lung diseases. Front Immunol (2013) 1.61
Epithelial cell proliferation contributes to airway remodeling in severe asthma. Am J Respir Crit Care Med (2007) 1.36
Airway smooth muscle in airway reactivity and remodeling: what have we learned? Am J Physiol Lung Cell Mol Physiol (2013) 1.23
β2-Agonist induced cAMP is decreased in asthmatic airway smooth muscle due to increased PDE4D. PLoS One (2011) 1.10
Extracellular matrix remodeling by dynamic strain in a three-dimensional tissue-engineered human airway wall model. Am J Respir Cell Mol Biol (2006) 1.09
Corticosteroid insensitivity of chemokine expression in airway smooth muscle of patients with severe asthma. J Allergy Clin Immunol (2012) 1.02
Mesenchymal stem cell transfer suppresses airway remodeling in a toluene diisocyanate-induced murine asthma model. Allergy Asthma Immunol Res (2011) 1.00
The pivotal role of airway smooth muscle in asthma pathophysiology. J Allergy (Cairo) (2011) 0.98
Airway smooth muscle in asthma: just a target for bronchodilation? Clin Chest Med (2012) 0.96
IL-22 contributes to TGF-β1-mediated epithelial-mesenchymal transition in asthmatic bronchial epithelial cells. Respir Res (2013) 0.92
Fstl1 Promotes Asthmatic Airway Remodeling by Inducing Oncostatin M. J Immunol (2015) 0.92
Airway remodeling in a mouse asthma model assessed by in-vivo respiratory-gated micro-computed tomography. Eur Radiol (2009) 0.90
Ca(2+)-activated K(+) channel-3.1 blocker TRAM-34 attenuates airway remodeling and eosinophilia in a murine asthma model. Am J Respir Cell Mol Biol (2012) 0.88
Airway smooth muscle STIM1 and Orai1 are upregulated in asthmatic mice and mediate PDGF-activated SOCE, CRAC currents, proliferation, and migration. Pflugers Arch (2012) 0.88
Airway smooth muscle proliferation and survival is not modulated by mast cells. Clin Exp Allergy (2009) 0.87
Anti-inflammatory dimethylfumarate: a potential new therapy for asthma? Mediators Inflamm (2013) 0.86
The irreversible component of persistent asthma. J Allergy Clin Immunol (2009) 0.86
The airway smooth muscle CCR3/CCL11 axis is inhibited by mast cells. Allergy (2008) 0.85
Cytokine and anti-cytokine therapy in asthma: ready for the clinic? Clin Exp Immunol (2009) 0.85
Epithelial expression of mRNA and protein for IL-6, IL-10 and TNF-alpha in endobronchial biopsies in horses with recurrent airway obstruction. BMC Vet Res (2008) 0.83
Recombinant rat CC10 protein inhibits PDGF-induced airway smooth muscle cells proliferation and migration. Biomed Res Int (2013) 0.82
Longitudinal changes in airway remodeling and air trapping in severe asthma. Acad Radiol (2014) 0.81
Associations of moderate to severe asthma with obstructive sleep apnea. Yonsei Med J (2013) 0.80
Airway smooth muscle chemokine receptor expression and function in asthma. Clin Exp Allergy (2009) 0.80
A microRNA network dysregulated in asthma controls IL-6 production in bronchial epithelial cells. PLoS One (2014) 0.79
Thymic stromal lymphopoietin induces migration in human airway smooth muscle cells. Sci Rep (2013) 0.79
Endobronchial Ultrasound Reliably Quantifies Airway Smooth Muscle Remodeling in an Equine Asthma Model. PLoS One (2015) 0.78
Orai channel-mediated Ca2+ signals in vascular and airway smooth muscle. Am J Physiol Cell Physiol (2015) 0.78
Tidal stretches differently regulate the contractile and cytoskeletal elements in intact airways. PLoS One (2014) 0.77
In vivo imaging of the airway wall in asthma: fibered confocal fluorescence microscopy in relation to histology and lung function. Respir Res (2011) 0.77
Influence of Asian dust particles on immune adjuvant effects and airway inflammation in asthma model mice. PLoS One (2014) 0.76
Smooth muscle CaMKIIδ promotes allergen-induced airway hyperresponsiveness and inflammation. Pflugers Arch (2015) 0.76
Risk Factors Associated with Irreversible Airway Obstruction in Asthma: A Systematic Review and Meta-Analysis. Biomed Res Int (2016) 0.76
The pharmacological modulation of allergen-induced asthma. Inflammopharmacology (2012) 0.76
M2 Muscarinic acetylcholine receptor modulates rat airway smooth muscle cell proliferation. World Allergy Organ J (2013) 0.75
Trans-basement membrane migration of eosinophils induced by LPS-stimulated neutrophils from human peripheral blood in vitro. ERJ Open Res (2015) 0.75
Soluble guanylyl cyclase is reduced in airway smooth muscle cells from a murine model of allergic asthma. World Allergy Organ J (2010) 0.75
Airway remodeling in asthma: what really matters. Cell Tissue Res (2017) 0.75
Mepolizumab for severe refractory eosinophilic asthma: evidence to date and clinical potential. Ther Adv Chronic Dis (2016) 0.75
Lymphotoxin β receptor signaling induces IL-8 production in human bronchial epithelial cells. PLoS One (2014) 0.75
Reconstruction is not renovation - the role of remodeling in asthma. J Asthma Allergy (2009) 0.75
Birefringence microscopy platform for assessing airway smooth muscle structure and function in vivo. Sci Transl Med (2016) 0.75
Profile of anti-IL-5 mAb mepolizumab in the treatment of severe refractory asthma and hypereosinophilic diseases. J Asthma Allergy (2015) 0.75
Epithelial Anion Transport as Modulator of Chemokine Signaling. Mediators Inflamm (2016) 0.75
Bronchial thermoplasty and the role of airway smooth muscle: are we on the right direction? Ther Clin Risk Manag (2017) 0.75
Regulation of human airway smooth muscle cell migration and relevance to asthma. Respir Res (2017) 0.75
Impaired Relaxation of Airway Smooth Muscle in Mice Lacking the Actin Binding Protein Gelsolin. Am J Respir Cell Mol Biol (2017) 0.75
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J (2013) 8.39
Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science (2004) 6.28
Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J Clin Invest (2003) 4.08
Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax (2012) 4.06
Inhaled corticosteroids in COPD and the risk of serious pneumonia. Thorax (2013) 3.62
Adult Asthma Consensus Guidelines update 2003. Can Respir J (2004) 3.61
Overdiagnosis of asthma in obese and nonobese adults. CMAJ (2008) 3.23
Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest (2003) 3.16
Increased risk of childhood asthma from antibiotic use in early life. Chest (2007) 3.11
Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. J Allergy Clin Immunol (2003) 2.98
Bronchodilator use and the risk of arrhythmia in COPD: part 1: Saskatchewan cohort study. Chest (2012) 2.65
T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma. J Allergy Clin Immunol (2009) 2.54
Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J Immunol (2009) 2.42
Should combination therapy with inhaled corticosteroids and long-acting beta2-agonists be prescribed as initial maintenance treatment for asthma? CMAJ (2002) 2.30
Diagnosis and management of work-related asthma: American College Of Chest Physicians Consensus Statement. Chest (2008) 2.27
Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. J Allergy Clin Immunol (2012) 2.24
Fluoroquinolones and the risk of serious arrhythmia: a population-based study. Clin Infect Dis (2012) 2.17
Increased IL-33 expression by epithelial cells in bronchial asthma. J Allergy Clin Immunol (2010) 2.17
Cardiovascular morbidity and mortality in COPD. Chest (2005) 2.01
Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol (2006) 2.00
Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults. Can Respir J (2012) 1.96
Injurious ventilation induces widespread pulmonary epithelial expression of tumor necrosis factor-alpha and interleukin-6 messenger RNA. Crit Care Med (2002) 1.93
Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. Am J Respir Crit Care Med (2007) 1.85
Chlorine-induced injury to the airways in mice. Am J Respir Crit Care Med (2003) 1.79
Upper airway muscle inflammation and denervation changes in obstructive sleep apnea. Am J Respir Crit Care Med (2004) 1.75
Gender differences in survival following hospitalisation for COPD. Thorax (2010) 1.73
Role of transforming growth factor-β in airway remodeling in asthma. Am J Respir Cell Mol Biol (2010) 1.71
The use of inhaled corticosteroids and the risk of adrenal insufficiency. Eur Respir J (2012) 1.67
Inhaled corticosteroids and the risks of diabetes onset and progression. Am J Med (2010) 1.66
IL-17 promotes p38 MAPK-dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation. J Immunol (2010) 1.65
Remodeling in asthma. J Allergy Clin Immunol (2011) 1.64
Canadian Pediatric Asthma Consensus guidelines, 2003 (updated to December 2004): introduction. CMAJ (2005) 1.63
S epsilon S mu and S epsilon S gamma switch circles in human nasal mucosa following ex vivo allergen challenge: evidence for direct as well as sequential class switch recombination. J Immunol (2003) 1.61
Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells. MBio (2012) 1.59
A high dose of adenosine to induce transient asystole for valvuloplasty in patients undergoing transcatheter aortic valve implantation (TAVI): is it a valid alternative to rapid pacing? A prospective pilot study. J Invasive Cardiol (2011) 1.56
Airway remodeling in subjects with severe asthma with or without chronic persistent airflow obstruction. J Allergy Clin Immunol (2009) 1.52
Chitinases and chitinase-like proteins in T(H)2 inflammation and asthma. J Allergy Clin Immunol (2005) 1.49
Involvement of the cysteinyl-leukotrienes in allergen-induced airway eosinophilia and hyperresponsiveness in the mouse. Am J Respir Cell Mol Biol (2003) 1.49
Control of airway inflammation maintained at a lower steroid dose with 100/50 microg of fluticasone propionate/salmeterol. J Allergy Clin Immunol (2006) 1.44
Vitamin D deficiency as a strong predictor of asthma in children. Int Arch Allergy Immunol (2011) 1.44
Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes. J Allergy Clin Immunol (2006) 1.43
Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia. J Allergy Clin Immunol (2013) 1.42
Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial. Thorax (2007) 1.42
Bronchodilator use and the risk of arrhythmia in COPD: part 2: reassessment in the larger Quebec cohort. Chest (2012) 1.42
The impact of main branch restenosis on long term mortality following drug-eluting stent implantation in patients with de novo unprotected distal left main bifurcation coronary lesions: the Milan and New-Tokyo (MITO) Registry. Catheter Cardiovasc Interv (2014) 1.41
Chlorine gas inhalation: human clinical evidence of toxicity and experience in animal models. Proc Am Thorac Soc (2010) 1.41
Proliferative aspects of airway smooth muscle. J Allergy Clin Immunol (2004) 1.40
Increased expression of ADAM33 and ADAM8 with disease progression in asthma. J Allergy Clin Immunol (2007) 1.40
IL-17E upregulates the expression of proinflammatory cytokines in lung fibroblasts. J Allergy Clin Immunol (2006) 1.37
Probing the viscoelastic behavior of cultured airway smooth muscle cells with atomic force microscopy: stiffening induced by contractile agonist. Biophys J (2005) 1.37
Airway remodeling in asthma. Allergol Int (2007) 1.36
Differences in airway cytokine profile in severe asthma compared to moderate asthma. Chest (2007) 1.36
Distribution of nitric oxide synthase in normal and cirrhotic human liver. Proc Natl Acad Sci U S A (2002) 1.33
Implementing practice guidelines: a workshop on guidelines dissemination and implementation with a focus on asthma and COPD. Can Respir J (2006) 1.32
Mechanisms of airway remodeling. Chest (2013) 1.30
Myosin, transgelin, and myosin light chain kinase: expression and function in asthma. Am J Respir Crit Care Med (2008) 1.27
IL-9 in allergic inflammation. Int Arch Allergy Immunol (2004) 1.27
Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis. Gut (2013) 1.26
CNODES: the Canadian Network for Observational Drug Effect Studies. Open Med (2012) 1.26
Geographic and gender variability in the prevalence of bronchial responsiveness in Canada. Chest (2004) 1.26
Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics. J Allergy Clin Immunol (2003) 1.23
Remodeling in asthma. Proc Am Thorac Soc (2009) 1.20
Prevalence of obstructive sleep apnea-hypopnea in severe versus moderate asthma. J Allergy Clin Immunol (2009) 1.18
A calcium-activated chloride channel (HCLCA1) is strongly related to IL-9 expression and mucus production in bronchial epithelium of patients with asthma. J Allergy Clin Immunol (2002) 1.16
Oral corticosteroids decrease eosinophil and CC chemokine expression but increase neutrophil, IL-8, and IFN-gamma-inducible protein 10 expression in asthmatic airway mucosa. J Allergy Clin Immunol (2005) 1.16
Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response. J Allergy Clin Immunol (2004) 1.16
IL-13 may mediate allergen-induced hyperresponsiveness independently of IL-5 or eotaxin by effects on airway smooth muscle. Am J Physiol Lung Cell Mol Physiol (2004) 1.16
Airway remodeling in asthma. Curr Opin Pharmacol (2010) 1.16
Childhood predictors of smoking in adolescence: a follow-up study of Montreal schoolchildren. CMAJ (2005) 1.16
Antigen-specific CD4+ T cells drive airway smooth muscle remodeling in experimental asthma. J Clin Invest (2005) 1.15
Th17-associated cytokines promote human airway smooth muscle cell proliferation. FASEB J (2012) 1.14